These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17300060)

  • 1. [Clinical and pharmacoeconomic perspective use of amoxicillin/sulbactam in the treatment of extra-hospital pneumonia].
    Sinopal'nikov AI; Zaĭtsev AA
    Voen Med Zh; 2006 Nov; 327(11):42-5. PubMed ID: 17300060
    [No Abstract]   [Full Text] [Related]  

  • 2. [Betalactam antibiotics combined with bectalactamases inhibitors. Amoxicillin-sulbactam].
    Barcelona L; Marín M; Stamboulian D
    Medicina (B Aires); 2008; 68(1):65-74. PubMed ID: 18416324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The clinical and pharmacoeconomic aspects of gemifloxacin(corrected) use in the patients with extra-hospital pneumonia in stationary conditions].
    Zaĭtsev AA; Sinopal'nikova AI
    Voen Med Zh; 2007 Jan; 328(1):44-51. PubMed ID: 17436714
    [No Abstract]   [Full Text] [Related]  

  • 4. How to treat children's pneumonia: a complex problem.
    Don M; Korppi M
    Eur Respir J; 2010 Apr; 35(4):932-3. PubMed ID: 20356993
    [No Abstract]   [Full Text] [Related]  

  • 5. [Amoxycillin/Sulbactam (Trifamox IBL) in prophylaxis and therapy of surgical site infections in oncologic patients].
    Mitrokhin SD; Sokolov AA
    Antibiot Khimioter; 2010; 55(7-8):34-41. PubMed ID: 21140563
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacoeconomic analysis of ampicillin-sulbactam versus cefoxitin in the treatment of intraabdominal infections.
    Messick CR; Mamdani M; McNicholl IR; Danziger LH; Rodvold KA; Condon RE; Walker AP; Edmiston CE
    Pharmacotherapy; 1998; 18(1):175-83. PubMed ID: 9469691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of combination therapy with ciprofloxacin and azlocillin in intensive care patients with pneumonia and/or sepsis.
    Engelhardt D; Ruckdeschel G
    J Chemother; 1989 Jul; 1(4 Suppl):788-9. PubMed ID: 16312640
    [No Abstract]   [Full Text] [Related]  

  • 8. A cost-effectiveness analysis of antimicrobial treatment of community-acquired pneumonia taking into account resistance in Belgium.
    Martin M; Moore L; Quilici S; Decramer M; Simoens S
    Curr Med Res Opin; 2008 Mar; 24(3):737-51. PubMed ID: 18230196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of childhood complicated community-acquired pneumonia with amoxicillin/sulbactam.
    Lovera D; Arbo A
    J Chemother; 2005 Jun; 17(3):283-8. PubMed ID: 16038522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cefoperazone-sulbactam for treatment of severe melioidosis.
    Apisarnthanarak A; Little JR
    Clin Infect Dis; 2002 Mar; 34(5):721-3. PubMed ID: 11823963
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness study comparing cefoperazone-sulbactam to a three-drug combination for treating intraabdominal infections in an Indian health-care setting.
    Kochhar P; Suvarna V; Duttagupta S; Sarkar S
    Value Health; 2008 Mar; 11 Suppl 1():S33-8. PubMed ID: 18387065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Estimation of the clinical and pharmacoeconomic efficiency of treatment in patients with community-acquired pneumonia with third-generation cephalosporins].
    Starodubtseva OI; Vakhrushev IaM
    Probl Tuberk Bolezn Legk; 2009; (6):28-9. PubMed ID: 19642570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of pharmacokinetic, pharmacodynamic and clinical studies with a modern combination of amoxicillin/sulbactam.
    Soutric J; Bantar C; Caruso N; Heguilén R; Casellas JM; Casellas JM; Farinati A; Jasovich A; Arenoso H; Rodriguez M
    Chemotherapy; 2006; 52(4):200-4. PubMed ID: 16720984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-acquired pneumonia: is it time to shorten the antibiotic treatment?
    Esposito S; Fiore M
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):933-8. PubMed ID: 18039078
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and economic outcomes in respiratory tract infections: The impact of bacterial resistance.
    Rapp RP
    Postgrad Med; 2002 Sep; 112(3 Suppl):12-7. PubMed ID: 19667590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination carbapenem-sulbactam therapy for critically ill patients with multidrug-resistant Acinetobacter baumannii bacteremia: four case reports and an in vitro combination synergy study.
    Lee NY; Wang CL; Chuang YC; Yu WL; Lee HC; Chang CM; Wang LR; Ko WC
    Pharmacotherapy; 2007 Nov; 27(11):1506-11. PubMed ID: 17963460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of respiratory tract infections with augmentin.
    Cioffi R; Turco D; Alfano B; Di Salvatore F; Gnasso P; Mastroianni S
    J Chemother; 1989 Jul; 1(4 Suppl):766-7. PubMed ID: 16312630
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia.
    Betrosian AP; Frantzeskaki F; Xanthaki A; Douzinas EE
    J Infect; 2008 Jun; 56(6):432-6. PubMed ID: 18501431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of amoxycillin-clavulanate in an experimental model of murine pneumonia caused by AmpC-non-hyperproducing clinical isolates of Escherichia coli resistant to cefoxitin.
    Docobo-Pérez F; Fernández-Cuenca F; Pachón-Ibáñez ME; Pascual A; Pichardo C; Martínez-Martínez L; Pachón J
    Clin Microbiol Infect; 2008 Jun; 14(6):582-7. PubMed ID: 18294246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.